Laxai Pharma, Ltd.
OTC: LAXAF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- J. Ram Ajjarapu
- Employees
- 1
- Headquarters
- Tampa, United States
- IPO year
- 1994
- Market cap
- $475.3K
Loading LAXAF…
Loading profile data…Frequently asked questions about LAXAF
What does Laxai Pharma, Ltd. (LAXAF) do?
Laxai Pharma, Ltd. is an American company that offers specialized contract research services. The firm provides extensive support throughout the entire pharmaceutical development process. Its areas of expertise include biostatistics, various data management methodologies (such as electronic, hybrid, and paper-based systems), CDISC advisory, medi...
Where does LAXAF trade?
Laxai Pharma, Ltd. (LAXAF) trades on the Other OTC.
What sector is LAXAF in?
Laxai Pharma, Ltd. (LAXAF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Laxai Pharma, Ltd.?
J. Ram Ajjarapu is the chief executive officer of Laxai Pharma, Ltd. (LAXAF).
Where is Laxai Pharma, Ltd. headquartered?
Laxai Pharma, Ltd. is headquartered in United States.
Does LAXAF pay a dividend?
Laxai Pharma, Ltd. (LAXAF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LAXAF go public?
Laxai Pharma, Ltd. (LAXAF) completed its initial public offering in 1994.